<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03504657</url>
  </required_header>
  <id_info>
    <org_study_id>FAHZU-2018-006</org_study_id>
    <nct_id>NCT03504657</nct_id>
  </id_info>
  <brief_title>Drug-coated Balloon Angioplasty for Patients With Symptomatic Vertebral Artery Stenosis</brief_title>
  <official_title>Drug-coated Balloon Angioplasty for Patients With Symptomatic Vertebral Artery Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Zhengzhou University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Posterior circulation stroke accounts for 20% of ischemic stroke. A quarter occurs in
      patients with stenosis in the vertebral and/or basilar arteries. Vertebral artery stenosis
      can be treated with stenting. However, in-stent restenosis rate have been reported as high as
      more than 30%, which may reduce the effect of stent therapy. Drug-coated balloon has shown
      good results in controlling neointimal hyperplasia in the femoral and popliteal arteries.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2018</start_date>
  <completion_date type="Anticipated">April 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Restenosis</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The composite of vascular death, myocardial infarction, or any stroke</measure>
    <time_frame>within 30 days after the start of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The composite of vascular death, myocardial infarction, or any stroke</measure>
    <time_frame>within 12 months after the start of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death resulting from any cause</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke in the supply territory of the symptomatic vertebral artery</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Serious adverse events</measure>
    <time_frame>30 days</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Vertebral Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>Drug-coated balloon angioplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>stenting angioplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Drug-coated balloon angioplasty</intervention_name>
    <description>Angioplasty with a drug-coated angioplasty</description>
    <arm_group_label>Drug-coated balloon angioplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stenting angioplasty</intervention_name>
    <description>Angioplasty with a stenting</description>
    <arm_group_label>stenting angioplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Patients presenting with posterior circulation transient ischemic attack or
             nondisabling stroke in the previous 6 months

          -  Vertebral artery origin stenosis resulting from presumed atheromatous disease with
             stenosis ≥50%

          -  Lesion length of the stenosis ＞5mm.

          -  Angioplasty can be performed within two weeks after randomization

          -  Female subjects of childbearing potential have a negative pregnancy test.

          -  Signed informed consent prior to entering study

        Exclusion Criteria:

          -  Potential cause of TIA or minor stroke other than stenosis in a vertebral artery (e.g.
             atrial fibrillation)

          -  Life expectancy shorter than 2 years

          -  Vertebral artery stenosis caused by dissection

          -  Vertebral stenting felt to be technically impracticable

          -  Previous stenting in randomized artery

          -  Pre-morbid modified Rankin scale score of greater than 3

          -  Currently participating or previously participated in any investigational drug or
             device study within 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chuanjie Wu, MD</last_name>
    <phone>008618911366882</phone>
    <email>wuchuanjie8557@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yajun Lian, MD</last_name>
      <phone>008613838367143</phone>
      <email>lianyajun369@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nanyang City Center Hospital</name>
      <address>
        <city>Nanyang</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Changming Wen, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>April 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Zhengzhou University</investigator_affiliation>
    <investigator_full_name>Chuanjie Wu</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Vertebral Artery Stenosis</keyword>
  <keyword>Drug-coated balloon angioplasty</keyword>
  <keyword>Stenting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Vertebrobasilar Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

